SA-Med Plc

Ethiopia Health

Sa-Med manufactures intravenous bags, intravenous administration sets and other medical device sterilisation services.

We are invested in SA-Med Plc through SGI Ethiopia Growth and Transformation Fund, which is managed by Schulze Global Ethiopia GP. For further information on the fund, the fund manager, and the expected impact of the fund’s investment, click here.

Key facts

Status:
Active
Region

Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.

:
Africa, East Africa
Countries:
Ethiopia
Sector

We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people.

:
Health
Investment type

We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).

:
Intermediated investment
Fund:
SGI Ethiopia Growth and Transformation Fund
Fund Manager:
Schulze Global Ethiopia GP
Start date

For direct investments, this is the date CDC committed capital to the business or project.

For funds, this is the date that CDC committed capital to the fund.

For underlying fund investments, this is the date that the fund invested capital into the business.e

:
June 2014
Domicile

This is the investee company’s place of incorporation; or a fund’s jurisdiction.

:
Ethiopia